Related Experiment Video
Updated: May 5, 2026

04:48
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
Published on: May 4, 2020
8.1K
Iron metabolism disorder and multiple sclerosis: a comprehensive analysis
Chao Tang1, Jiaxin Yang2, Chaomin Zhu2
1Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Frontiers in Immunology
|April 9, 2024
Summary
This study reveals key genes and iron metabolism markers linked to multiple sclerosis (MS). Findings suggest iron metabolism disorders play a role in MS pathogenesis, offering new avenues for treatment.
Area of Science:
- Neuroimmunology
- Genetics
- Metabolomics
Background:
- Multiple sclerosis (MS) is a prevalent chronic inflammatory central nervous system disease.
- The precise pathological mechanisms of MS remain incompletely understood.
- Disordered iron metabolism is increasingly implicated in MS onset and progression.
Purpose of the Study:
- To investigate the association between iron metabolism and multiple sclerosis (MS) using integrated bioinformatics and Mendelian randomization.
- To identify potential diagnostic biomarkers for MS related to iron metabolism.
- To explore the causal relationship between iron metabolism markers and MS.
Main Methods:
- Utilized publicly available gene expression databases.
- Applied bioinformatics techniques: differential expression analysis, weighted correlation network analysis, gene enrichment analysis, and logistic regression.
- Conducted Mendelian randomization to assess causality between iron metabolism markers and MS.
Main Results:
- Identified six genes (IREB2, LAMP2, ISCU, ATP6V1G1, ATP13A2, SKP1) associated with MS and iron metabolism, demonstrating a multi-gene diagnostic value (AUC=0.83).
- Mendelian randomization indicated a potential causal link between transferrin saturation and MS (p=0.022).
- Mendelian randomization suggested a potential causal relationship between serum transferrin and MS (p=0.0002).
Conclusions:
- The study establishes a significant link between iron metabolism and MS pathogenesis.
- Identified novel multi-gene diagnostic markers for MS.
- Provides theoretical support for targeting iron metabolism in MS treatment strategies.
Related Concept Videos
Disorders of Erythrocytes
2.7K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20

